apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer (2022) Beck M, Semrau S, Haderlein M, Gostian AO, Hartwich J, Müller SK, Kallies A, et al. Journal article Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials (2022) Zhou JG, Wong AHH, Wang H, Jin SH, Tan F, Chen YZ, He SS, et al. Journal article Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials (2022) Zhou J, Zeng Y, Wang H, Jin SH, Wang YJ, He S, Frey B, et al. Journal article Interaction of Radiotherapy and Hyperthermia with the Immune System: a Brief Current Overview (2022) Sengedorj A, Hader M, Frey B, Fietkau R, Ott O, Gaipl U, Rückert M Journal article Deep learning for brain metastasis detection and segmentation in longitudinal MRI data (2022) Huang Y, Bert C, Sommer P, Frey B, Gaipl U, Distel L, Weissmann T, et al. Journal article Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods (2022) Zhou JG, Wong AHH, Wang H, Tan F, Chen X, Jin SH, He SS, et al. Journal article Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. (2022) Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, et al. Conference contribution F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial (2022) Beck M, Hartwich J, Eckstein M, Schmidt D, Gostian AO, Müller-Hübner SKU, Rutzner S, et al. Journal article Editorial: Immune-Related Adverse Events for Patients With Lung Cancer (2022) Yang R, Wang H, Yin X, Frey B, Gaipl U, Shi H, Ma X Journal article, Editorial Altered activation of the immune response causes radioresistance in HR-impaired breast cancer cells (2022) Classen S, Rahlf E, Jungwirth J, Poole L, Gehre S, Rückert M, Petersen C, et al. Conference contribution